All Stories
All Impact Stories
10
Minute Read

A Spartan Changing the Way We Fight Cancer

Written by
Matt Davenport
Published on
January 10, 2024
MSU IQ

Carolina de Aguiar Ferreira couldn’t do what she does anywhere else.

The assistant professor has the resources at Michigan State University to precisely target cancer cells with diagnostics and therapies using radioisotopes produced by what is designed to be the world's most powerful heavy-ion accelerator.

She works in the highly collaborative Institute for Quantitative Health Science and Engineering, or IQ, and the isotopes come from the Facility for Rare Isotope Beams, a U.S. Department of Energy Office of Science user facility located in the heart of campus.

When considering where to pursue her career, she knew MSU provided the perfect environment.

“I wanted to work in a place where people work together,” de Aguiar Ferreira says. “We learn better together. We teach better together. We discover better together.”

De Aguiar Ferreira’s commitment to community took root while she was growing up in Brazil, where her love of science also bloomed.

As a child, de Aguiar Ferreira played games with her pharmacist grandfather designed to stoke her curiosity. In town, he was also known as “the alchemist” for his ability to diagnose and treat his neighbors’ illnesses.

He died while she was in graduate school, but in his loss, she also found validation. Her grandfather, who helped inspire her career, had colon cancer, which was the focus of de Aguiar Ferreira’s research project.

“That was a sign to me that I was doing the right thing with my life,” she says.

Now in the colleges of Human Medicine and Engineering at MSU, she’s working with some of the top minds in her field and attracting some of the most talented students in the world to better treat cancer and improve lives.

“It makes me feel like I’m part of something bigger.”

No items found.

No items found.
Matt Davenport
Author Email
Author Email
No items found.
News

MSU Health Sciences News

Get the latest updates on our programs and initiatives.

Henry Ford + MSU Researchers Collaborate to Shift Pancreatic Cancer Outlook From Bleak to Bright

Henry Ford Health and MSU researchers are teaming up to change the outlook for pancreatic cancer patients. With cutting-edge research on genetic indicators and promising RAS inhibitors, the team is working toward earlier detection and improved treatment options.

Rx Kids Celebrates Program’s First Birthday, Shares Milestones

More than 1,300 babies and families in the city of Flint have received nearly $6 million in cash prescriptions since Rx Kids launched in January 2024.

What’s New in the Treatment of Sickle Cell Disease?

Discover the latest advancements in sickle cell disease (SCD) treatment from MSU Health Care expert Dr. Shawn Jobe. Learn about new gene therapies, common challenges SCD patients face, and how MSU’s Sickle Cell Disease Lifespan Clinic supports patients transitioning to adult care.